Bradford J. Gessner, M.D., M.P.H.

Vice President Global Medical Lead for Respiratory Vaccines
Pfizer Biopharma Group
Collegeville, Pennsylvania, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 1019 - Respiratory Syncytial Virus (RSV) Diagnoses in Hospitalized Patients Increases when Additional Specimen Types are Added to Nasopharyngeal Swab: Results from the RSV in Adults Multispecimen Study

  Thursday, October 12, 2023
  3:15 PM - 3:33 PM US ET

• 1942 - Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV among US Infants

  Friday, October 13, 2023
  2:15 PM - 2:30 PM US ET